
Chronic thromboembolic pulmonary hypertension (CTEPH) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051110

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines details of the PBS subsidised biological agent
for patients with CTEPH.

CTEPH and listing dates

Chronic thromboembolic pulmonary hypertension is a condition resulting
in blood flow obstruction through the lungs.

Listing dates: riociguat - 1 January 2017.

Enquiries

Transfer enquiries about prescription arrangements to the Complex Drugs
Programs team and choose the team relevant to the condition treated.

The Resources page contains links to application forms, contact details,
item codes, restriction, a quick reference guide, the PBS and Services
Australia websites.

Related links

Processing and National Demand Allocation (PaNDA)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Process telephone authority approval application

Written Authority Required Drugs

Processing Written Authority Required Listings

                                   

-   Services Australia ABN 90 794 605 008 
